LD50 and ED50.pptx

K
Methods to calculate
LD50 and ED50
Dr. Karabi Adak
MBBS, Md
Dose–Response Relationships
The pharmacodynamics of a drug can be quantified by
the relationship between the dose (concentration) of
the drug and the organism's (patient's) response to that
drug.
2 major types of dose–response relationships—graded
and quantal:
Graded dose–response relationships describe the
effect of various doses of a drug on an individual.
Quantal dose–response relationships show the effect
of various doses of a drug on a population of individuals.
Graded dose–response relationships
……Graded dose–response relationships
Two important parameters—potency and efficacy
The potency (EC50) of a drug is the concentration at which
the drug elicits 50% of its maximal response.
The efficacy (Emax) is the maximal response produced by the
drug.
No inter-individual variation.
Quantal Dose–Response Relationships
Plots the fraction of the population that responds to a given
dose of drug as a function of the drug dose.
The response is all-or-none.
Differences in biological response among individuals - the
effects of a drug are seen over a range of doses.
Flat curve denotes a broad range of sensitivity, a steep one
denotes a very narrow range
…….Quantal Dose–Response Relationships
Types of responses:
Median effective dose (ED50): dose at which 50% of
subjects/animals exhibit a therapeutic response to a drug.
Median toxic dose (TD50): dose at which 50% of subjects
experience a toxic response.
Median lethal dose (LD50): dose at which is lethal to 50% of
subjects.
LD50 and ED50.pptx
…….Quantal Dose–Response Relationships
Values are different for each route of administration.
Both LD50 and ED50 values are important for knowing the
safety of a drug.
The ratio between LD50 and ED50 (LD50/ED50) represents
therapeutic index(TI).
Greater the TI, safer is the drug and vice-versa.
…….Quantal Dose–Response Relationships
The TI of most of the drugs which have low margin of
safety is generally close to unity.
ED99 dose that is effective in 99% of the animals of the
group.
LD10 dose that is lethal to 10% of the animals of the group.
LD50 and ED50 are mainly determined in acute toxicity
studies.
Acute Toxicity Studies
Acute toxicity refers to those adverse effects occurring
following oral administration of a single dose of a
substance, or multiple doses within 24 hr.
Aims at establishing the therapeutic index (TI)
Several species of animals are used to determine LD50
(due to species variation)
A drug effect seen both in the rat and dog probably
involves a common physiological mechanism that is
likely to be present in the human, whereas an effect
seen only in one of the two species indicate that the
same is peculiar to that species, and is less likely to be
present in the third species.
……..Acute Toxicity Studies
In practice, it is considered sufficiently adequate if LD50
with confidence limits is established on one common
laboratory species, mice or rats by the standard method.
It is unwise to use a homogenous strains (inbred strains) in
toxicity study, and the aim should be to discover new and
unexpected effects of a drug in animals of wider variability
like random bred animals.
LD50 dose, thus found is then given to guinea pigs, rabbits,
cats or dogs on the basis of their weight or surface areas.
Requirements of a toxicity study
 Should follow GLP
 Studies should be performed by well trained and
qualified staff.
 Instruments should be calibrated and standardized
properly.
 SOPs should be followed.
Acute Toxicity Test Design
First performed in mice fasted overnight (18hours)
Two rodents species(mice and rats); in each group at least 5
animals of either sex.
Route of administration-
• Same as intended for humans.
• At least one more route should be used in one of the species
to ensure systemic absorption of the drug.
• LD50 values increase with the following sequences of
routes: intravenous, intraperitoneal, subcutaneous and oral.
……Acute Toxicity Test Design
Doses-
At least three graded dose. A limit of 2g/kg (or 10 times
the normal dose that is intended in humans, whichever is
higher) is recommended for oral dosing.
Treatment- given in a single bolus or several doses or by
continuous infusion within 24 hr.
In rodents, the volume should not normally exceed
1ml/100g of body weight; however in the case of aqueous
solutions, 2 ml/100g body weight can be considered.
……Acute Toxicity Test Design
Observations-
Animals should be observed for 14 days after the drug
administration, and minimum lethal dose (MLD) and
maximum tolerated dose (MTD) and LD50 should be
established. Other features to be observed are-
Signs of intoxication
Effect on body weight
Gross pathological changes
……Acute Toxicity Test Design
Alternative method…..
Each dose given to one animal only
LD50 estimated from mean of the logarithms of the smallest
effective dose and the largest ineffective dose.
Up and down’ or ‘staircase’ method
First described by Dixon and Mood.
2 mice injected with a particular dose, eg: 175mg/kg
………Up and down’ or ‘staircase’ method
Observe for 48 hours
Dose tolerated- increase by a factor of 3.2
Dose lethal- decrease by a factor of 3.2
Maximum nonlethal dose and minimum lethal dose are thus
determined by using only about 10 mice
Economical in animal but not in time
Methods for calculating ED50
 Dixon & Massey’s method
 Reed & Muench method
 Probit method of Gaddum & Bliss
 Wilson & Worcester method
 Knudson & Curtis method
 Thompson method
 Kärber's method
Kärber's method
Based on the “S” shaped dose-response curve
The drug dosage are arranged by geometric progression
growth.
60 mice weighed, divided into 6 groups randomly, 10 mice
per group. Average weight of each group should be roughly
equal.
Geometric proportion diluents made according to the
calculated dosages.
Mice observed for 30-50 minutes after administration.
Mice showing response counted.
Positive reaction rate of each group calculated.
Table filled with the results.
…..Kärber'smethod
……Kärber's method
• ED50 calculated by the formula:
• Where, Xk=logarithm of the maximum dosage.
• i=logarithm of the ratio of the adjacent doses.
• is the sum of the positive rate of each group. P1,P2,P3,……
is the positive rate of each group.
Methods for calculating LD50
Lichtfield and Wilcoxon (1949) - Graphical method
L.C Miller and Tainter (1944) – Logarithmic probit graph
paper method
De Beer (1945) – Graphical method
Reed and Muench (1938) – Arithmetical method
Kärber (1931) – Arithmetical method
Lorke’s Method
Graphical calculation of Lichtfield and
Wilcoxon(1949)
Permits rapid estimation of LD50, slope of a dose-
percent effect curve, and the confidence limits of
both parameters for 19/20 probability using the
experimental data in their original form.
Graphical calculation of L.C Miller and Tainter
(1944)
Most commonly used method
Acurate and simple
Percentage mortality noted in the groups of animals
% 0 1 2 3 4 5 6 7 8 9
0 - 2.67 2.95 3.12 3.25 3.36 3.45 3.52 3.59 3.66
10 3.72 3.77 3.82 3.87 3.92 3.96 4.01 4.05 4.08 4.12
20 4.16 4.19 4.23 4.26 4.29 4.33 4.36 4.39 4.42 4.45
30 4.48 4.50 4.53 4.56 4.59 4.61 4.64 4.67 4.69 4.72
40 4.75 4.77 4.80 4.82 4.85 4.87 4.90 4.92 4.95 4.97
50 5.00 5.03 5.05 5.08 5.10 5.13 5.15 5.18 5.20 5.23
60 5.25 5.28 5.31 5.33 5.36 5.39 5.41 5.44 5.47 5.50
70 5.5
2
5.5
5
5.58 5.6
1
5.6
4
5.67 5.7
1
5.74 5.77 5.81
80 5.8
4
5.8
8
5.92 5.9
5
5.9
9
6.04 6.0
8
6.13 6.18 6.23
90 6.28 6.34 6.41 6.48 6.55 6.64 6.75 6.88 7.05 7.33
Group Dose
(mg/kg)
Log
dose
Dead/
Total
Dead
%
Corrected
%
Probit
1 64 1.81 0/10 0 2.5 3.04
2 71 1.85 2/10 20 20 4.16
3 81 1.91 4/10 40 40 4.75
4 90 1.95 9/10 90 90 6.28
5 100 2.00 10/10 100 97.5 6.96
Table: Results of acute toxicity study in mice
PROBIT
LOG DOSE
3
4
5
6
7
1.8 1.9 2.0
Correction factor applied to 0 and 100% mortality group
 Correction for 0% dead = 100(0.25/n)
 Correction for 100% dead = 100×(n-0.25/n)
 Percentage mortality values converted to probit
(Probability integral transformation) values.
 The log dose is plotted in X- axis.
 Probit scale is plotted in Y-axis.
 The LD50 is equal to the antilog dose corresponding to
probit 5 (50%)
 In this example, the value is antilog of 1.9, i.e.,
79.5mg/kg (LD50).
Arithmetical method of Kärber (1931)
No dose response curve
Simplest, rapid but crude method
Use the interval mean of the number dead (Mean mortality)
in each group of animals and the difference between the
doses (dose difference) for the same interval
Mean mortality= total of two adjacent no of dead animal/2
e.g. (0+2) /2 = 1
Dose difference e.g. 71-64= 7
…..Arithmetical method of Kärber
Product of the interval mean and the dose difference is
obtained (a×b) e.g 7×1=7
The product is summed up i.e., Ʃ (a×b) = 190.5
Now dividing the value by no of animals in each group =
190.5/10 = 19.05
Finally this value is subtracted from the minimum dose
which produces the 100% mortality, i.e. 100 mg/kg
So, LD50 = 100-(190.5/10) = 81 mg/kg (approx)
Exp.
Group
Dose
(mg/kg)
Dose
differene
(a)
No. of
animals
(n)
No.of
dead
animals
Mean
Mortality
(b)
a×b
1 64 _ 10 0 - -
2 71 7 10 2 1 7
3 81 10 10 4 3 30
4 90 9 10 9 6.5 58.5
5 100 10 10 10 9.5 95
Arithmetical method of Reed and Muench (1938)
Employs a cumulative value.
Less reliable than Miller and Tainter method.
Assumption:
Animals killed by a certain dose would have been killed
by a larger dose
A surviving animal would have survived a smaller dose
Table: Toxicity computed by Reed and Muench Method
Cumulative
response
Group Dose Dead Survived Dead Survived Total
%
Survive
d
1 100 10 0 10 25 35
_
2 90 9 1 19 25 44 -
3 81 4 6 23 24 47 51.1
4 71 2 8 25 18 43 41.9
5 64 0 10 25 10 35
_
(0.9)X log 1.14= 0.054
Log 71= 1.85
Log LD50=1.85+ 0.054= 1.9
Antilog 1.9= LD50= 79.5 mg/kg
1.14=log
1.14=0.06
=
….Reed and Muench Method
….Reed and Muench Method
The cumulative dead are recorded
The cumulative survivors are recorded upward
% survival for both doses adjacent to the LD50 is computed
Proportionate distance from 50% is computed
Logarithm of the proportionate dose increment computed
….Reed and Muench Method
Proportionate distance from 50% X logarithm of the
proportionate dose increment.
This is added to the logarithm of the smaller adjacent dose
to form log LD50.
Antilog of the above value gives LD50.
Lorke’s Method
Phase 1:
Three-groups of three mice each.
One dose to each group i.p.
Monitored for 24 h for mortality and general behaviour.
Phase 2:
3–4 groups of one mouse each given doses i.p. based on the
findings of phase 1
Monitored for 24 h.
The geographic mean of the least dose that killed mice and
the highest dose that did not kill mice was taken as the
median lethal dose.
Conclusion
For many reasons TI is not a useful guide to safety
of a drug in clinical use:
LD50 based on animal toxicity data, may not
reflect toxicity in the therapeutic setting ,where
unwanted effects are rarely common but not
death.
LD50 takes no account of idiosyncratic reactions.
ED50 not definable, depends on what measures of
effectiveness is used.
1 sur 37

Recommandé

OECD Guidline on acute and chronic toxicity par
OECD Guidline on acute and chronic toxicityOECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicityShital Magar
34.7K vues61 diapositives
Basic definition and types of toxicology par
Basic definition and types of toxicologyBasic definition and types of toxicology
Basic definition and types of toxicologyAbhishekJoshi312
11.8K vues24 diapositives
Assignment on Toxicology par
Assignment on ToxicologyAssignment on Toxicology
Assignment on ToxicologyDeepak Kumar
50.3K vues84 diapositives
Regulatory guidelines for conducting toxicity studies par
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesHimikaRathi
21K vues69 diapositives
Acute toxicity studies-425 par
Acute toxicity studies-425Acute toxicity studies-425
Acute toxicity studies-425jeshicabulsara
12.9K vues30 diapositives
OECD Guidelines par
OECD GuidelinesOECD Guidelines
OECD GuidelinesUrmila Aswar
20K vues61 diapositives

Contenu connexe

Tendances

Oecd guidelines for toxicology studies par
Oecd guidelines for toxicology studiesOecd guidelines for toxicology studies
Oecd guidelines for toxicology studiesJasdeep singh brar
45.5K vues44 diapositives
Ld 50 par
Ld 50Ld 50
Ld 50Dr.Ameya Puranik
26.2K vues23 diapositives
Acute oral toxicity –acute class method par
Acute oral toxicity –acute class methodAcute oral toxicity –acute class method
Acute oral toxicity –acute class methodDr Ajay Mandal
9K vues29 diapositives
DRUG RESPONSE LD50, ED50 AND THERAPEUTIC INDEX- par
DRUG RESPONSELD50,ED50 ANDTHERAPEUTIC INDEX-DRUG RESPONSELD50,ED50 ANDTHERAPEUTIC INDEX-
DRUG RESPONSE LD50, ED50 AND THERAPEUTIC INDEX-Saajida Sultaana
18.1K vues9 diapositives
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411). par
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).helasri gummadi
10.2K vues29 diapositives
Toxicology and its types by Kashikant Yadav par
Toxicology and its types by Kashikant YadavToxicology and its types by Kashikant Yadav
Toxicology and its types by Kashikant YadavKashikant Yadav
39.6K vues38 diapositives

Tendances(20)

Acute oral toxicity –acute class method par Dr Ajay Mandal
Acute oral toxicity –acute class methodAcute oral toxicity –acute class method
Acute oral toxicity –acute class method
Dr Ajay Mandal9K vues
DRUG RESPONSE LD50, ED50 AND THERAPEUTIC INDEX- par Saajida Sultaana
DRUG RESPONSELD50,ED50 ANDTHERAPEUTIC INDEX-DRUG RESPONSELD50,ED50 ANDTHERAPEUTIC INDEX-
DRUG RESPONSE LD50, ED50 AND THERAPEUTIC INDEX-
Saajida Sultaana18.1K vues
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411). par helasri gummadi
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
helasri gummadi10.2K vues
Toxicology and its types by Kashikant Yadav par Kashikant Yadav
Toxicology and its types by Kashikant YadavToxicology and its types by Kashikant Yadav
Toxicology and its types by Kashikant Yadav
Kashikant Yadav39.6K vues
Analgesic screening methods par shubhaasharma
Analgesic screening methodsAnalgesic screening methods
Analgesic screening methods
shubhaasharma27.9K vues
screening of hypoglycemic agent par Azhar iqbal
screening of hypoglycemic agentscreening of hypoglycemic agent
screening of hypoglycemic agent
Azhar iqbal1.9K vues
How to investigate behavior and cognitive abilities in rodents in a social gr... par InsideScientific
How to investigate behavior and cognitive abilities in rodents in a social gr...How to investigate behavior and cognitive abilities in rodents in a social gr...
How to investigate behavior and cognitive abilities in rodents in a social gr...
Screening of antipyretic drugs par drarunsingh4
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugs
drarunsingh43.9K vues
Screening methods for skin sensitization, skin irritation and dermal toxicity... par Ch. Bhargava krishna
Screening methods for skin sensitization, skin irritation and dermal toxicity...Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening Models for Diuretics Agents.pptx par MonishaReddy31
Screening Models for Diuretics Agents.pptxScreening Models for Diuretics Agents.pptx
Screening Models for Diuretics Agents.pptx
MonishaReddy31239 vues
Screening hypnotic activity par Dr. Pooja
Screening hypnotic activityScreening hypnotic activity
Screening hypnotic activity
Dr. Pooja4.4K vues

Similaire à LD50 and ED50.pptx

Animal Toxicity Studies par
Animal Toxicity StudiesAnimal Toxicity Studies
Animal Toxicity StudiesKartickMahaldar1
531 vues37 diapositives
Doses.pdf par
Doses.pdfDoses.pdf
Doses.pdfProf. Dr Pharmacology
61 vues62 diapositives
Oecd guide line2 par
Oecd guide line2Oecd guide line2
Oecd guide line2drkamalsahil
461 vues28 diapositives
Oecd guide line2 par
Oecd guide line2Oecd guide line2
Oecd guide line2drkamalsahil
6.7K vues28 diapositives
Bioassay par
BioassayBioassay
BioassayMy_VivJaan
183.4K vues38 diapositives
111135 (3) par
111135 (3)111135 (3)
111135 (3)amit acharzo
191 vues12 diapositives

Similaire à LD50 and ED50.pptx(20)

Bioassay par My_VivJaan
BioassayBioassay
Bioassay
My_VivJaan183.4K vues
Acute oral toxicity-UDP : oecd-425 par Dr Ajay Mandal
Acute oral toxicity-UDP : oecd-425Acute oral toxicity-UDP : oecd-425
Acute oral toxicity-UDP : oecd-425
Dr Ajay Mandal8.5K vues
Subacute toxicity par vaniarlekar
Subacute toxicitySubacute toxicity
Subacute toxicity
vaniarlekar54.1K vues
Invivo screening methods for anti inflammatory agents par Sravani Ganti
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
Sravani Ganti35.8K vues
OECD Guideline For Acute oral toxicity (TG 423) par Naveen K L
OECD Guideline For Acute oral toxicity (TG 423)OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)
Naveen K L7.5K vues
Acute, sub acute toxic studies toxicology pharmacology par subodhhipr
Acute, sub acute toxic studies toxicology pharmacologyAcute, sub acute toxic studies toxicology pharmacology
Acute, sub acute toxic studies toxicology pharmacology
subodhhipr1.7K vues
Screening of anti psychotic drugs salim par salim82
Screening of anti psychotic drugs  salimScreening of anti psychotic drugs  salim
Screening of anti psychotic drugs salim
salim828.1K vues
Screening models for acute eye irritation & skin sentization par pradnya Jagtap
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentization
pradnya Jagtap2.4K vues

Dernier

Prodrugs par
ProdrugsProdrugs
ProdrugsDr. Ajmer Singh Grewal
23 vues113 diapositives
CCDI Kibbe Wake Forest University Dec 2023.pptx par
CCDI Kibbe Wake Forest University Dec 2023.pptxCCDI Kibbe Wake Forest University Dec 2023.pptx
CCDI Kibbe Wake Forest University Dec 2023.pptxWarren Kibbe
20 vues51 diapositives
Children with Disabilities and Environmental Factors par
Children with Disabilities and Environmental FactorsChildren with Disabilities and Environmental Factors
Children with Disabilities and Environmental FactorsOlaf Kraus de Camargo
33 vues24 diapositives
Extraordinary Far Infrared Technology - Raising Frequencies with far infrared... par
Extraordinary Far Infrared Technology - Raising Frequencies with far infrared...Extraordinary Far Infrared Technology - Raising Frequencies with far infrared...
Extraordinary Far Infrared Technology - Raising Frequencies with far infrared...corey268189
60 vues87 diapositives
Impact of ICF on collaboration and communication par
Impact of ICF on collaboration and communicationImpact of ICF on collaboration and communication
Impact of ICF on collaboration and communicationOlaf Kraus de Camargo
28 vues19 diapositives
Scrotal and Testicular Swelling.pptx par
Scrotal and Testicular Swelling.pptxScrotal and Testicular Swelling.pptx
Scrotal and Testicular Swelling.pptxMichael Sintayehu
23 vues74 diapositives

Dernier(20)

CCDI Kibbe Wake Forest University Dec 2023.pptx par Warren Kibbe
CCDI Kibbe Wake Forest University Dec 2023.pptxCCDI Kibbe Wake Forest University Dec 2023.pptx
CCDI Kibbe Wake Forest University Dec 2023.pptx
Warren Kibbe20 vues
Extraordinary Far Infrared Technology - Raising Frequencies with far infrared... par corey268189
Extraordinary Far Infrared Technology - Raising Frequencies with far infrared...Extraordinary Far Infrared Technology - Raising Frequencies with far infrared...
Extraordinary Far Infrared Technology - Raising Frequencies with far infrared...
corey26818960 vues
communication and nurse patient relationship by Tamanya Samui.pdf par TamanyaSamui1
communication and nurse patient relationship by Tamanya Samui.pdfcommunication and nurse patient relationship by Tamanya Samui.pdf
communication and nurse patient relationship by Tamanya Samui.pdf
TamanyaSamui141 vues
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx par ABG
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptxINTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx
ABG121 vues
Buccoadhesive drug delivery System.pptx par ABG
Buccoadhesive drug delivery System.pptxBuccoadhesive drug delivery System.pptx
Buccoadhesive drug delivery System.pptx
ABG169 vues
Explore new Frontiers in Medicine with AI.pdf par Anne Marie
Explore new Frontiers in Medicine with AI.pdfExplore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdf
Anne Marie20 vues
Biomedicine & Pharmacotherapy par Trustlife
Biomedicine & PharmacotherapyBiomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy
Trustlife254 vues
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad par Swetha rani Savala
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP par MohamadAlhes
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
MohamadAlhes110 vues

LD50 and ED50.pptx

  • 1. Methods to calculate LD50 and ED50 Dr. Karabi Adak MBBS, Md
  • 2. Dose–Response Relationships The pharmacodynamics of a drug can be quantified by the relationship between the dose (concentration) of the drug and the organism's (patient's) response to that drug. 2 major types of dose–response relationships—graded and quantal: Graded dose–response relationships describe the effect of various doses of a drug on an individual. Quantal dose–response relationships show the effect of various doses of a drug on a population of individuals.
  • 4. ……Graded dose–response relationships Two important parameters—potency and efficacy The potency (EC50) of a drug is the concentration at which the drug elicits 50% of its maximal response. The efficacy (Emax) is the maximal response produced by the drug. No inter-individual variation.
  • 5. Quantal Dose–Response Relationships Plots the fraction of the population that responds to a given dose of drug as a function of the drug dose. The response is all-or-none. Differences in biological response among individuals - the effects of a drug are seen over a range of doses. Flat curve denotes a broad range of sensitivity, a steep one denotes a very narrow range
  • 6. …….Quantal Dose–Response Relationships Types of responses: Median effective dose (ED50): dose at which 50% of subjects/animals exhibit a therapeutic response to a drug. Median toxic dose (TD50): dose at which 50% of subjects experience a toxic response. Median lethal dose (LD50): dose at which is lethal to 50% of subjects.
  • 8. …….Quantal Dose–Response Relationships Values are different for each route of administration. Both LD50 and ED50 values are important for knowing the safety of a drug. The ratio between LD50 and ED50 (LD50/ED50) represents therapeutic index(TI). Greater the TI, safer is the drug and vice-versa.
  • 9. …….Quantal Dose–Response Relationships The TI of most of the drugs which have low margin of safety is generally close to unity. ED99 dose that is effective in 99% of the animals of the group. LD10 dose that is lethal to 10% of the animals of the group. LD50 and ED50 are mainly determined in acute toxicity studies.
  • 10. Acute Toxicity Studies Acute toxicity refers to those adverse effects occurring following oral administration of a single dose of a substance, or multiple doses within 24 hr. Aims at establishing the therapeutic index (TI) Several species of animals are used to determine LD50 (due to species variation) A drug effect seen both in the rat and dog probably involves a common physiological mechanism that is likely to be present in the human, whereas an effect seen only in one of the two species indicate that the same is peculiar to that species, and is less likely to be present in the third species.
  • 11. ……..Acute Toxicity Studies In practice, it is considered sufficiently adequate if LD50 with confidence limits is established on one common laboratory species, mice or rats by the standard method. It is unwise to use a homogenous strains (inbred strains) in toxicity study, and the aim should be to discover new and unexpected effects of a drug in animals of wider variability like random bred animals. LD50 dose, thus found is then given to guinea pigs, rabbits, cats or dogs on the basis of their weight or surface areas.
  • 12. Requirements of a toxicity study  Should follow GLP  Studies should be performed by well trained and qualified staff.  Instruments should be calibrated and standardized properly.  SOPs should be followed.
  • 13. Acute Toxicity Test Design First performed in mice fasted overnight (18hours) Two rodents species(mice and rats); in each group at least 5 animals of either sex. Route of administration- • Same as intended for humans. • At least one more route should be used in one of the species to ensure systemic absorption of the drug. • LD50 values increase with the following sequences of routes: intravenous, intraperitoneal, subcutaneous and oral.
  • 14. ……Acute Toxicity Test Design Doses- At least three graded dose. A limit of 2g/kg (or 10 times the normal dose that is intended in humans, whichever is higher) is recommended for oral dosing. Treatment- given in a single bolus or several doses or by continuous infusion within 24 hr. In rodents, the volume should not normally exceed 1ml/100g of body weight; however in the case of aqueous solutions, 2 ml/100g body weight can be considered.
  • 15. ……Acute Toxicity Test Design Observations- Animals should be observed for 14 days after the drug administration, and minimum lethal dose (MLD) and maximum tolerated dose (MTD) and LD50 should be established. Other features to be observed are- Signs of intoxication Effect on body weight Gross pathological changes
  • 16. ……Acute Toxicity Test Design Alternative method….. Each dose given to one animal only LD50 estimated from mean of the logarithms of the smallest effective dose and the largest ineffective dose. Up and down’ or ‘staircase’ method First described by Dixon and Mood. 2 mice injected with a particular dose, eg: 175mg/kg
  • 17. ………Up and down’ or ‘staircase’ method Observe for 48 hours Dose tolerated- increase by a factor of 3.2 Dose lethal- decrease by a factor of 3.2 Maximum nonlethal dose and minimum lethal dose are thus determined by using only about 10 mice Economical in animal but not in time
  • 18. Methods for calculating ED50  Dixon & Massey’s method  Reed & Muench method  Probit method of Gaddum & Bliss  Wilson & Worcester method  Knudson & Curtis method  Thompson method  Kärber's method
  • 19. Kärber's method Based on the “S” shaped dose-response curve The drug dosage are arranged by geometric progression growth. 60 mice weighed, divided into 6 groups randomly, 10 mice per group. Average weight of each group should be roughly equal. Geometric proportion diluents made according to the calculated dosages. Mice observed for 30-50 minutes after administration. Mice showing response counted. Positive reaction rate of each group calculated. Table filled with the results.
  • 21. ……Kärber's method • ED50 calculated by the formula: • Where, Xk=logarithm of the maximum dosage. • i=logarithm of the ratio of the adjacent doses. • is the sum of the positive rate of each group. P1,P2,P3,…… is the positive rate of each group.
  • 22. Methods for calculating LD50 Lichtfield and Wilcoxon (1949) - Graphical method L.C Miller and Tainter (1944) – Logarithmic probit graph paper method De Beer (1945) – Graphical method Reed and Muench (1938) – Arithmetical method Kärber (1931) – Arithmetical method Lorke’s Method
  • 23. Graphical calculation of Lichtfield and Wilcoxon(1949) Permits rapid estimation of LD50, slope of a dose- percent effect curve, and the confidence limits of both parameters for 19/20 probability using the experimental data in their original form. Graphical calculation of L.C Miller and Tainter (1944) Most commonly used method Acurate and simple Percentage mortality noted in the groups of animals
  • 24. % 0 1 2 3 4 5 6 7 8 9 0 - 2.67 2.95 3.12 3.25 3.36 3.45 3.52 3.59 3.66 10 3.72 3.77 3.82 3.87 3.92 3.96 4.01 4.05 4.08 4.12 20 4.16 4.19 4.23 4.26 4.29 4.33 4.36 4.39 4.42 4.45 30 4.48 4.50 4.53 4.56 4.59 4.61 4.64 4.67 4.69 4.72 40 4.75 4.77 4.80 4.82 4.85 4.87 4.90 4.92 4.95 4.97 50 5.00 5.03 5.05 5.08 5.10 5.13 5.15 5.18 5.20 5.23 60 5.25 5.28 5.31 5.33 5.36 5.39 5.41 5.44 5.47 5.50 70 5.5 2 5.5 5 5.58 5.6 1 5.6 4 5.67 5.7 1 5.74 5.77 5.81 80 5.8 4 5.8 8 5.92 5.9 5 5.9 9 6.04 6.0 8 6.13 6.18 6.23 90 6.28 6.34 6.41 6.48 6.55 6.64 6.75 6.88 7.05 7.33
  • 25. Group Dose (mg/kg) Log dose Dead/ Total Dead % Corrected % Probit 1 64 1.81 0/10 0 2.5 3.04 2 71 1.85 2/10 20 20 4.16 3 81 1.91 4/10 40 40 4.75 4 90 1.95 9/10 90 90 6.28 5 100 2.00 10/10 100 97.5 6.96 Table: Results of acute toxicity study in mice
  • 27. Correction factor applied to 0 and 100% mortality group  Correction for 0% dead = 100(0.25/n)  Correction for 100% dead = 100×(n-0.25/n)  Percentage mortality values converted to probit (Probability integral transformation) values.  The log dose is plotted in X- axis.  Probit scale is plotted in Y-axis.  The LD50 is equal to the antilog dose corresponding to probit 5 (50%)  In this example, the value is antilog of 1.9, i.e., 79.5mg/kg (LD50).
  • 28. Arithmetical method of Kärber (1931) No dose response curve Simplest, rapid but crude method Use the interval mean of the number dead (Mean mortality) in each group of animals and the difference between the doses (dose difference) for the same interval Mean mortality= total of two adjacent no of dead animal/2 e.g. (0+2) /2 = 1 Dose difference e.g. 71-64= 7
  • 29. …..Arithmetical method of Kärber Product of the interval mean and the dose difference is obtained (a×b) e.g 7×1=7 The product is summed up i.e., Ʃ (a×b) = 190.5 Now dividing the value by no of animals in each group = 190.5/10 = 19.05 Finally this value is subtracted from the minimum dose which produces the 100% mortality, i.e. 100 mg/kg So, LD50 = 100-(190.5/10) = 81 mg/kg (approx)
  • 30. Exp. Group Dose (mg/kg) Dose differene (a) No. of animals (n) No.of dead animals Mean Mortality (b) a×b 1 64 _ 10 0 - - 2 71 7 10 2 1 7 3 81 10 10 4 3 30 4 90 9 10 9 6.5 58.5 5 100 10 10 10 9.5 95
  • 31. Arithmetical method of Reed and Muench (1938) Employs a cumulative value. Less reliable than Miller and Tainter method. Assumption: Animals killed by a certain dose would have been killed by a larger dose A surviving animal would have survived a smaller dose
  • 32. Table: Toxicity computed by Reed and Muench Method Cumulative response Group Dose Dead Survived Dead Survived Total % Survive d 1 100 10 0 10 25 35 _ 2 90 9 1 19 25 44 - 3 81 4 6 23 24 47 51.1 4 71 2 8 25 18 43 41.9 5 64 0 10 25 10 35 _
  • 33. (0.9)X log 1.14= 0.054 Log 71= 1.85 Log LD50=1.85+ 0.054= 1.9 Antilog 1.9= LD50= 79.5 mg/kg 1.14=log 1.14=0.06 = ….Reed and Muench Method
  • 34. ….Reed and Muench Method The cumulative dead are recorded The cumulative survivors are recorded upward % survival for both doses adjacent to the LD50 is computed Proportionate distance from 50% is computed Logarithm of the proportionate dose increment computed
  • 35. ….Reed and Muench Method Proportionate distance from 50% X logarithm of the proportionate dose increment. This is added to the logarithm of the smaller adjacent dose to form log LD50. Antilog of the above value gives LD50.
  • 36. Lorke’s Method Phase 1: Three-groups of three mice each. One dose to each group i.p. Monitored for 24 h for mortality and general behaviour. Phase 2: 3–4 groups of one mouse each given doses i.p. based on the findings of phase 1 Monitored for 24 h. The geographic mean of the least dose that killed mice and the highest dose that did not kill mice was taken as the median lethal dose.
  • 37. Conclusion For many reasons TI is not a useful guide to safety of a drug in clinical use: LD50 based on animal toxicity data, may not reflect toxicity in the therapeutic setting ,where unwanted effects are rarely common but not death. LD50 takes no account of idiosyncratic reactions. ED50 not definable, depends on what measures of effectiveness is used.